Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Vertex Pharmaceuticals

    NASDAQ: VRTX · Real-Time Price · USD
    450.66
    -4.79 (-1.05%)
    At close: Jun 16, 2025, 3:59 PM
    450.00
    -0.15%
    After-hours: Jun 16, 2025, 07:48 PM EDT

    Vertex Pharmaceuticals Statistics

    Share Statistics

    Vertex Pharmaceuticals has 256.8M shares outstanding. The number of shares has increased by -0.49% in one year.

    Shares Outstanding

    n/a
    		 256.8M

    Shares Change (YoY)

    n/a
    		 -0.49%

    Shares Change (QoQ)

    n/a
    		 -0.29%

    Owned by Institutions (%)

    n/a
    		 91.62%

    Shares Floating

    n/a
    		 256M

    Failed to Deliver (FTD) Shares

    n/a
    		 8,654

    FTD / Avg. Volume

    n/a
    		 0.51%

    Short Selling Information

    The latest short interest is 4.41M, so 1.72% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.41M

    Short % of Shares Out

    n/a
    		 1.72%

    Short % of Float

    n/a
    		 1.94%

    Short Ratio (days to cover)

    n/a
    		 2.89

    Valuation Ratios

    The PE ratio is -193.61 and the forward PE ratio is 22.09. Vertex Pharmaceuticals's PEG ratio is 1.69.

    PE Ratio

    n/a
    		 -193.61

    Forward PE

    n/a
    		 22.09

    PS Ratio

    n/a
    		 9.41

    Forward PS

    n/a
    		 6.7

    PB Ratio

    n/a
    		 6.32

    P/FCF Ratio

    n/a
    		 -131.21

    PEG Ratio

    n/a
    		 1.69
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Vertex Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.69, with a Debt / Equity ratio of 0.11.

    Current Ratio

    n/a
    		 2.69

    Quick Ratio

    n/a
    		 2.35

    Debt / Equity

    n/a
    		 0.11

    Debt / EBITDA

    n/a
    		 3.6

    Debt / FCF

    n/a
    		 -2.21

    Interest Coverage

    n/a
    		 -7.61

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,806,573.77

    Profits Per Employee

    n/a
    		 $-87,803.28

    Employee Count

    n/a
    		 6,100

    Asset Turnover

    n/a
    		 0.49

    Inventory Turnover

    n/a
    		 1.27

    Taxes

    Income Tax

    n/a
    		 784.1M

    Effective Tax Rate

    n/a
    		 315.53%

    Stock Price Statistics

    The stock price has increased by -5.21% in the last 52 weeks. The beta is 0.42, so Vertex Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.42

    52-Week Price Change

    n/a
    		 -5.21%

    50-Day Moving Average

    n/a
    		 463.03

    200-Day Moving Average

    n/a
    		 465.7

    Relative Strength Index (RSI)

    n/a
    		 52.59

    Average Volume (20 Days)

    n/a
    		 1,705,130

    Income Statement

    In the last 12 months, Vertex Pharmaceuticals had revenue of 11.02B and earned -535.6M in profits. Earnings per share was -2.08.

    Revenue

    n/a
    		 11.02B

    Gross Profit

    n/a
    		 9.49B

    Operating Income

    n/a
    		 -232.9M

    Net Income

    n/a
    		 -535.6M

    EBITDA

    n/a
    		 486.3M

    EBIT

    n/a
    		 279.1M

    Earnings Per Share (EPS)

    n/a
    		 -2.08
    Full Income Statement

    Balance Sheet

    The company has 4.57B in cash and 1.75B in debt, giving a net cash position of 2.82B.

    Cash & Cash Equivalents

    n/a
    		 4.57B

    Total Debt

    n/a
    		 1.75B

    Net Cash

    n/a
    		 2.82B

    Retained Earnings

    n/a
    		 9.61B

    Total Assets

    n/a
    		 22.88B

    Working Capital

    n/a
    		 6.23B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -492.6M and capital expenditures -297.7M, giving a free cash flow of -790.3M.

    Operating Cash Flow

    n/a
    		 -492.6M

    Capital Expenditures

    n/a
    		 -297.7M

    Free Cash Flow

    n/a
    		 -790.3M

    FCF Per Share

    n/a
    		 -3.07
    Full Cash Flow Statement

    Margins

    Gross margin is 86.11%, with operating and profit margins of -2.11% and -4.86%.

    Gross Margin

    n/a
    		 86.11%

    Operating Margin

    n/a
    		 -2.11%

    Pretax Margin

    n/a
    		 2.25%

    Profit Margin

    n/a
    		 -4.86%

    EBITDA Margin

    n/a
    		 4.41%

    EBIT Margin

    n/a
    		 -2.11%

    FCF Margin

    n/a
    		 -7.17%

    Dividends & Yields

    VRTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for VRTX is $520, which is 14.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $520

    Price Target Difference

    n/a
    		 14.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 26
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 24, 2000. It was a forward split with a ratio of 2:1.

    Last Split Date

    n/a
    		 Aug 24, 2000

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 2:1

    Scores

    Altman Z-Score

    n/a
    		 12.19

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist